Sleep Disorders Trial, Recruiting NCT05985811 Sponsor: Salem Anaesthesia Pain Clinic Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT05985811
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults who are living with chronic (long-term) pain
  • People who have a mood disorder alongside their chronic pain
  • People who also experience chronic insomnia (ongoing, persistent difficulty sleeping)
  • People who are already receiving regular ketamine injections as part of their pain treatment
  • People who have shown good compliance with their treatment (meaning they follow their treatment plan consistently)
  • People who have given consent for their clinical records to be reviewed for quality assurance purposes

Who may not be able to join:

  • People with a severe cognitive disorder (serious problems with thinking, memory, or understanding)
  • People who are unable to give informed consent to participate
  • People with a major neuropsychiatric disorder (a serious condition affecting both the brain and mental health — confirm with trial site)
  • People who use cannabis
  • People who use stimulants (such as amphetamines or similar substances)
  • People with a history of substance abuse
  • People who have not been following their treatment plan consistently
  • People who are not currently receiving ketamine injections for pain treatment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Olumuyiwa Bamgbade, MD,FRCPC, Salem Anaesthesia Pain Clinic

Phone: 17786286600

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Salem Anaesthesia Pain Clinic
Registry
ClinicalTrials.gov
Start date
2 February 2018
Est. completion
31 December 2025

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Pain score, objective measurement using the validated Numeric Pain Rating scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov